Abstract
Background: The emergence of multidrug-resistant (MDR) microorganisms is one of the biggest and most challenging public health issues drawing considerable attention of the scientific community. Here, we present an easy, one-step, inexpensive and ecofriendly/biologically mediated synthesis of Aloe vera-conjugated silver nanoparticles (Av-AgNPs) where the aqueous plant extract acts as a reducing and stabilizing agent and the resultant conjugate exhibits remarkable potential to limit/inhibit the growth of MDR pathogens.
Results: The nanosynthesis concluded in 4–6 h at 65°C and was followed by detailed characterization of the bioconjugated Av-AgNPs (with and without fabrication on cellulosic materials i.e., cotton fabric and filter paper) using a combination of UV–visible spectroscopy, Fourier transform infrared spectroscopy (FTIR), scanning electron microscopy (SEM), x-ray diffraction (XRD) and inductively coupled plasma optical emission spectroscopy (ICP-OES). The so-characterized NPs showed growth inhibitory effects on multiple strains including the Gram-positive Staphylococcus aureus, Gram-negative Escherichia coli (E. coli), Acinetobacter baumannii (A. baumannii), Pseudomonas aeruginosa (P. pseudomonas) and, more importantly, the fungus Candida albicans (C. albicans), when analyzed using the Kirby-Bauer method. A notable reduction in the colony-forming unit (CFU) counts of the E. coli (present in contaminated drinking water) was also observed when the filter paper encrusted with Av-AgNPs was applied as a filtration material.
Conclusions: In conclusion, the biofabricated Av-AgNPs are easy to synthesize and are a cost-effective alternative to inorganic AgNPs, with considerable antimicrobial activity, deserving further investigations for biomedical applications.
Upon acceptance of an article by the journal, authors will be asked to transfer the copyright to Electronic Journal of Biotechnology, which is committed to maintain the electronic access to the journal and to administer a policy of fair control and ensure the widest possible dissemination of the information. The author can use the article for academic purposes, stating clearly the following: "Published in Electronic Journal of Biotechnology at DOI:10.2225/volXX-issueX-fulltext-XX".
The Copyright Transfer Agreement must be submitted as a signed scanned copy to biotec@ucv.cl. All authors must send a copy of this document.